中/EN: 中文繁體 English

Investor Relations
IR Home Corporate Overview Financial Highlights Financial Reports ESG Reports Regulatory Filings Press Releases Company Presentations Stock Quotes & Charts Analyst Coverage FAQs IR Contact
Corporate

Press Releases

2025

Please select

MAR
25

The United Laboratories International Holdings Limited Announces 2024 Annual Results, Steady Performance with Innovation-Driven Transformation and Global Strategy, Profit Attributable to Shareholders Reaches RMB2,659.7 Million, Declared Final Dividend of RMB28 Cents Per Share and Special Dividend of RMB12 Cents Per Share

MAR
24

The United Laboratories and Novo Nordisk Announce Exclusive License Agreement for UBT251, a GLP-1/GIP/Glucagon Triple Receptor Agonist